Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-27

Clinical Trial Update: A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44 [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating CT image quality of Lumentin 44 for subjects undergoing abdominal CT, with terminated status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lumentin 44

Snippet

Sponsor: Lument AB | Conditions: Subjects Referred to CT-examination of the Abdomen | Phase 2 | Status: TERMINATED | Results posted: 2020-10-27